Acylated uridine and cytidine and uses thereof

Details Acylated uridine and cytidine and uses thereof Acylated uridine and cytidine and uses thereof

2006-09-12

2006-09-12

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S050000, C536S028500, C536S028530

Reexamination Certificate

active

07105498

ABSTRACT:
The invention relates to compositions comprising acyl derivatives of cytidine and uridine. The invention also relates to methods of treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease, infant respiratory distress syndrome and for enhancement of phospholipid biosynthesis comprising administering the acyl derivatives of the invention to an animal.

REFERENCES:
patent: 3161565 (1964-12-01), Gustave et al.
patent: 3585188 (1971-06-01), Marumoto et al.
patent: 3847898 (1974-11-01), Kelly et al.
patent: 3868451 (1975-02-01), Stein et al.
patent: 3894000 (1975-07-01), Wechter et al.
patent: 3975367 (1976-08-01), Gish et al.
patent: 3991045 (1976-11-01), Ishida et al.
patent: 4022963 (1977-05-01), Deutsh
patent: 4868162 (1989-09-01), Kawaguchi et al.
patent: 5141943 (1992-08-01), Naguib et al.
patent: 5470838 (1995-11-01), von Borstel et al.
patent: 5583117 (1996-12-01), von Borstel et al.
patent: 6258795 (2001-07-01), von Borstel et al.
patent: 6274563 (2001-08-01), von Borstel et al.
patent: 6316426 (2001-11-01), von Borstel et al.
patent: 0222192 (1987-05-01), None
patent: 1297398 (1972-11-01), None
patent: 1473148 (1977-05-01), None
patent: E-135918 (1991-06-01), None
patent: 3-169815 (1991-07-01), None
patent: WO 85/00608 (1985-02-01), None
patent: WO 89/03837 (1989-05-01), None
patent: WO 89/03838 (1989-05-01), None
Translation of Office Action mailed Jun. 1, 2004 in counterpart Japanese Patent Application No. 510442/94.
Derwent Publications Ltd.; JP 03/135918 A (Jun. 1991) XP-002029812 (Abstract).
Williams et al, “Studies Using Orotic Acid for . . . ,” Supplement 2, vol. 6, Aust. N.Z.J. Med., pp. 60-71 (1976).
Kypson et al, “Effects of Uridine . . . ” Journal of Molecular and Cellular Cardiology, vol. 10, pp. 545-565 (1978).
Rossi et al, “Pyrimidine nucleotide metabolism in . . . ,” European Heart Journal, vol. 5, pp. 155-162 (1984).
Williams et al, “Studies Using Orotic Acid . . . ,” Supplement 2, vol. 6, Aust. N.Z.J. Med., pp. 60-71 (1976).
Swain et al, “Derangementsin myocardial purine . . . ,” Proc. Natl. Acad. Sci. USA, vol. 79, pp. 655-659 (1982).
Kypson et al, “Metabolic Effects of Inosine and . . . ,” Biochemical Pharmacology, vol. 26, pp. 1585-1591 (1977).
Pastoris et al, “Modification of the skeletal muscle . . . ,” Pharm. Ed. Sci., vol. 40, p. 442-453 (1985).
Kypson et al, “Effects of uridine and inosine on glucose . . . ,” The Journal of Pharmacology and Experimental Therapeutics, vol. 199, No. 3, pp. 565-574 (1976).
Gasser et al, “Novel Single-Pass Exchange . . . ,” Science, vol. 213, pp. 777-778 (1981).
Kubes et al, “Comparison of the bioavailability . . . ,” Cancer Chemother Pharmacol, vol. 17, pp. 236-240 (1986).
Bucher et al, “Ribonucleic acid synthesis in relation . . . ,” Biochim. Biophys. Acta vol. 174, pp. 491-502 (1969).
Bushma et al, “Effect of Cytidine and Uridine . . . ,” Bull. Exp. Biol. Med., vol. 88, pp. 1480-1483 (1980).
Chernukh et al, “Effect of liver RNA on the course . . . ,” Bull. Exp. Biol. Med., vol. 70, pp. 1112-1114 (1970).
Diamondstone et al, “Differential Response of Inducible . . . ,” Biochim. Biophys. Acta., pp. 583-587 (1962).
Elrick et al, “Influence of Certain Nucleosides . . . ,” Metabolism, vol. Xi, No. 1, pp. 46-55 (1962).
Yamada et al, “Pyrimidine Nucleoside Phosphorylases of Rat Liver,” The Journal of Biological Chemistry, vol. 243, No. 7, Issue of Apr. 10, pp. 1649-1655 (1968).
Shah et al, “Wound healing and repair . . . ,” J. Anim. Morphol. Physiol., vol. 25, No. 1 and 2, pp. 193-200 (1978).
Shah et al, “Wound healing and repair . . . ,” J. Anim. Morphol. Physiol., vol. 21, No. 2, pp. 132-139 (1974).
Songu et al, “The Relationship Between Uracil Nucleotide . . . ,” Metabolism, vol. 30, No. 2, pp. 119-122 (1981).
Trovarelli et al, “The influence of cytidine on the endogenous pool . . . ,” Neurochemical Research, vol. 9, No. 1, pp. 73-78 (1984).
Dwivedi et al, “Anticonvulsant . . . ,” Toxicology and Applied Pharmacology, vol. 31, pp. 452-458 (1975).
Geiger et al, “Cytidine and Uridine Requirement,” Journal of Neurochemistry, vol. 1, pp. 93-100 (1956).
Beranek et al, “Selective O-acylation . . . ,” Collection Czechoslov. Chem. Commun. (vol. 42) pp. 367-369 (1977).
Sasaki et al, “Selective Acylation of the Amino . . . ,” Chem. Pharm. Bull., vol. 15, No. 6, pp. 894-896 (1967).
Samoilova et al, “Polyermic N-Hydroxysuccinimide . . . ,” Bull. Acad. Sci. USSR Div. Chem.. Sci. vol. 30, pp. 1306-1310 (1981).
Reese et al. “2'-O-acyl Ribonucleoside Derivatives,” Tetrahedron Letters, No. 29, pp. 2459-2465 (1965).
Chemical Abstracts, The American Chemical Society, vol. 105, No. 13, p. 456 (1986).
Lortet et al, “Pyrimidine nucleotide synthesis . . . ,” Basic Res. in Cardiol. vol. 81, pp. 302-310 (1986).
Schwartz et al, “Evaluation of (+)-Cyclaradine-5'-Esters . . . ,” Antimicrobial Agents and Chemotherapy, vol. 31, No. 7, pp. 998-1001 (1987).
Rosowsky et al, “Thymidine 5'-O-pivaloate . . . ” Cancer Treatment Reports, vol. 65, No. 1-2, pp. 93-99 (1981).
Martin et al, “Use of oral uridine as a substitute . . . ,” Cancer Chemother Pharmacol, vol. 24, pp. 9-14 *1989).
Casida et al, “3',5'-Diesters of 5-fluoro . . . ,” Biochemical Pharmacology, vol. 15, pp. 627-644 (1966).
Ensminger et al, Biochem. Pharm., 28:1541-1545, 1979.
Martin et al, J. Pharm. Sci. , vol. 76, No. 2, 180-184 (1987).
Hackh's Chemical Dictionary, 3rded. Julius Grant, ed. pp. 44, 45, 332-333, 1976.
Rajabalee, the Chemical Abstracts, 74:112368K (1971).
Bushman et al, the Chemical Abstracts, 92:105249r (1980).
Kypson et al, the Chemical Abstracts, 87:194780u (1977).
Aussedat, “Cardiovasc. Res.,” 17:145-151 (1983).
Aussedat et al, “Mol. Physiol.,” 6:247-256 (1984).
Aussedat et al, “J. Physiol.” 78:331-336 (1982).
Buckley et al, “Circ. Res.,” 7:847-867 (1959).
Kypson et al, “J. Mol. Cell. Cardiol.,” 10:545-565 (1978).
Rossi et al, “European Heart Journal,” 5:155-162 (1984).
Williams et al, “Aust. N.Z. J. Med.,” 6:Supp. 2, 60-71 (1976).
Swain et al, “P.N.A.S. (USA)” 79:655-659 (1982).
Kypson et al, “Biochem. Pharmacol.,” 26:1585-1591 (1977).
Pastoris et al, “Pharm. Ed. Sci.,” 40:442-453 (1985).
Kypson et al, “J. Pharm. Exp. Ther.,” 199-565-574 (1976).
Gasser et al, “Science” 213:777-778 (1981).
Klubes et al, “Cancer Chemother. Pharmacol.” 17:236-240 (1986).
Bucher et al, “Biochem. Phys. Acta,” 174-491-502 (1969).
Bushma et al, “Bull. Exp. Biol. Med.”,88:1480-1483 (1980).
Chemukh et al, “Bull. Exp. Biol. Med.,” 70:1112-1114 (1970).
Elrick et al, “Metabolism” 11:46-55 (1962).
Yamada et al, “J. Biol. Chem.” 243:1649-1655 (1968).
Shah et al, “J. Anim. Morphol. Physiol.” 25:193-200 (1978).
Shah et al, “J. Anim. Morphol. Physiol.” 21:132-139 (1974).
Songu et al, “Metabolism” 30:119-122 (1981).
Trovarelli et al, “Neurochemical Research” 9:73-79 (1984).
Dwivedi et al, “Toxicol. Appl. Pharmacol.” 31:452 (1978).
Geiger et al, “J. Neurochem.,” 1:93 (1956).
Beranek et al, “Collection Czechslovak Chem. Commun.,” 42:366-369 (1977).
Sasaki et al, “Chem. Pharm. Bull,” 15:894-896 (1967).
Watanabe et al, “Angew. Chem.,” 78:589 (1986).
Reese et al, “Tetrahedron Letters,” 29:2459-2465 (1965).
Lortet et al, The Chemical Abstracts, 105:112608y (1986).
Lortet et al, Basic Res. Cardiol. 81:303-310 (1988).
Lim et al, Antimicrobiol Agents and Chemotherapy,

Affiliated with

Also associated with

Rating

Acylated uridine and cytidine and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acylated uridine and cytidine and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated uridine and cytidine and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3611012